Tevogen Bio Holdings Inc. (TVGN)

Tevogen Bio Holdings Inc. (TVGN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $46M; returns 1 day -4.1%, 1 week -7.6%, 1 year -79.5%.

Tevogen Bio Holdings Inc. (TVGN) is a clinical-stage specialty immunotherapy company focused on developing off-the-shelf precision T cell therapies for infectious diseases, cancers, and other disorders. The company aims to create cost-efficient and accessible therapies by leveraging its artificial intelligence and precision T cell therapy platforms.

Groups TVGN belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Clinical Stage
• Immunotherapy
• Healthcare
• Oncology
• Life Sciences
• Precision Medicine
• Artificial Intelligence
• AI in Healthcare
• Infectious Diseases
• Clinical Stage Biopharma
• COVID-19

TVGN financial model: income statement, cash flow and balance sheet